Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1041230104Recruiting
Single-arm trial of remimazolam and sevoflurane, sponsored by Kobayashi Kensuke. Primary endpoint: Bispectral Index < 60. Started Nov 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1041230104.